James Demetriades (often referred to as Jim) is the Founder and CEO of Kairos Ventures. See sector focus and contact routes.
James Demetriades (often referred to as Jim) is the Founder and CEO of Kairos Ventures, a Beverly Hills-based venture capital firm he established in 2015 to commercialize scientific discoveries from universities. His investment thesis focuses on early-stage technologies in sectors like therapeutics, targeting Seed through Series B rounds to solve humanity’s greatest challenges. Kairos has invested in over 50 portfolio companies, though specific typical check sizes and whether Demetriades leads or follows deals are not publicly detailed. Notable named portfolio companies include Provivi, a commercial physical research firm where he serves as a board member, and the firm’s broader portfolio of groundbreaking technologies. Demetriades distinguishes his approach by partnering directly with universities to identify leading scientific discoveries before commercialization, a model he describes as a “new style of venture capital investing”. He has publicly discussed this philosophy on platforms like Mooch FM, emphasizing the transformative power of scientific innovation.
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Beverly Hills.
Investors like James Demetriades · Full investor directory · Investor access · Company funding database